Tag: Intensive Care
Caseload Strain Linked to Patient Survival During Delta Wave of COVID-19
One in five COVID-19 deaths due to strain-attributable mortality; findings were consistent across hospital types
Recreational Drug Use Tied to Repeat Cardiovascular Events
Findings seen for repeat events within one year of discharge from intensive cardiac care unit
Study Reveals MASLD, MetALD Responsible for One-Third of ICU Cirrhosis Cases
Metabolic dysfunction-associated steatotic liver disease has similar outcomes to alcohol-related liver disease
Nirsevimab Effective Against RSV-Linked Bronchiolitis Hospitalization
Nirsevimab therapy also effective against RSV-linked bronchiolitis resulting in critical care, ventilatory support for infants
Liberal Transfusion Strategy Not Beneficial for Patients With TBI, Anemia
No significant change seen in unfavorable neurologic outcome as assessed by score on GOS-E at six months
Cannabis Use Tied to Risk of COVID-19 Hospitalizations, ICU Admissions
Findings even after considering cigarette smoking, vaccination status, comorbidities, and other risk factors
Triglyceride-Glucose Index Independently Linked to All-Cause Mortality
Association with in-hospital and one-year mortality seen for patients with heart failure and chronic kidney disease
Marked Increase in Pediatric RSV Hospitalizations Seen Postpandemic
Additionally, there have been higher advanced respiratory support needs in older children with fewer comorbidities than prepandemic
Pantoprazole Cuts GI Bleeding in Patients Undergoing Invasive Ventilation
Pantoprazole yields lower clinically important upper GI bleeding, with no significant change in mortality versus placebo
Prolonged β-Lactam Antibiotic Infusions Aid Sepsis, Septic Shock Outcomes
Lower risk seen for 90-day mortality and intensive care unit mortality
